Health Economics and Outcomes Research 

Elevating healthcare with comprehensive real-world evidence

20%

of the global disease burden lies in Africa, but real-world evidence (RWE) of this is often missing in global clinical trials. Metaphor generates robust RWE from this region through comprehensive health economics and outcomes research that supports clinical development, market access and regulatory submissions.

Our kind of data

Our approach focuses on capturing the full picture of patient experiences and clinical outcomes across various therapeutic areas.

Comprehensive RWE

We gather evidence by tracking patient prognosis, medication usage, clinical events, quality of life metrics, and survival rates (progression free, overall and RECIST for solid tumors).

Diverse Therapeutic Coverage

Our services provide crucial insights into a range of therapeutic areas with high unmet needs in Africa, such as oncology, infectious diseases, and women’s health.

Expert team support

We utilize a multidisciplinary approach that combines expert personnel with advanced data management systems to ensure comprehensive and reliable data.

Program Managers

Overseeing the entire process, our program managers coordinate between various stakeholders for seamless project management. They ensure that each study is meticulously planned and executed to meet unique research objectives.

Clinical Research Coordinators

Our coordinators work closely with patients and healthcare providers to gather essential data on clinical outcomes and patient-reported outcomes (PROs). Their expertise ensures high-quality data collection that reflects real-world settings.

Data Analysts

Our data analysts are responsible for maintaining data integrity, overseeing its storage, cleaning, and analysis.

Pricing and Value Assessment

In today’s value-driven healthcare environment, demonstrating the economic benefits of your products is crucial. Our services provide the financial insights needed to support market access and pricing strategies for sustainable revenue.

Cost-Effectiveness Analysis 

This strategy compares costs and outcomes with existing standards of care to demonstrate the economic value of your products to distributors, regulators, and healthcare providers.

Budget Impact Analysis 

We project the financial implications of adopting your product within healthcare systems and provide detailed insights that help stakeholders understand the potential budgetary effects to inform decision-making.

Willingness-to-Pay Studies 

Understanding the maximum amount that patients or sponsors are willing to pay for your product is essential for pricing strategies. Our studies offer real-world evidence into the perceived value of your product.

Cost Recovery Strategies

Our experts analyze the economic landscape to help you identify and capitalize on opportunities for cost recovery whether through sales, licensing, or strategic partnerships. 

Comprehensive Value Dossiers 

We develop comprehensive value dossiers to demonstrate the clinical, economic, and patient-reported benefits of your products as evidence to support negotiations on their commercial value. 

We generate real-world evidence of drug efficacy, safety and outcomes for a wide range of conditions. Our data can accelerate market access, inform pricing strategies, and expand opportunities in emerging markets.

Value Proposition 

Partnering with Metaphor for your health outcomes research in Africa offers several strategic advantages

Clinical Advantages

Accelerate Clinical Development

Leverage African patient populations to speed up your clinical development timelines.

Robust Real-World Evidence

Generate strong evidence to support regulatory submissions and market access efforts, with data that reflects the unique healthcare needs and outcomes of African populations.

Unique Market Insights

Gain unparalleled insights into drug performance and patient experiences in underserved African markets to optimize your product offerings.

Budget-Friendly Solutions

Reduce costs compared to traditional global clinical trials by tapping into our local expertise and infrastructure.